Human cardiac fibroblasts expressing VCAM1 improve heart function in postinfarct heart failure rat models by stimulating lymphangiogenesis
نویسندگان
چکیده
منابع مشابه
Cardiac function and heart failure.
coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol 2001;88:693–5. 12. Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP. Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001;104: 2205–9. 13. Bellamy MF, Pellikka PA, Klarich KW, Tajik ...
متن کاملHuge Intracavitary Cardiac Hyadatid Cyst Presenting with Heart Failure
Although cardiac involvement is an infrequent presentation in human hydatidosis, early diagnosis and prompt surgical intervention of cardiac hydatid cyst are of utmost importance for the prevention of potential complications. We report a young female patient who presented with a huge cardiac hydatid cyst and severe heart failure symptoms undergoing successful surgical cyst removal with late fol...
متن کاملReprogrammed cardiac fibroblasts to the rescue of heart failure.
Heart failure is a leading cause of death worldwide. It is often the result of acute or chronic ischemic heart injury. Because the adult heart does not have the capacity to replace the injured cardiomyocytes, this inevitably leads to loss of cardiomyocytes, fibrosis, and loss of pump function. Many efforts have been put into cell-based therapy, in hope that exogenously delivered cells could rep...
متن کاملHeart failure CARDIAC TRANSPLANTATION
As a consequence of improved management in acute coronary syndromes and improved longevity of the population, the number of patients with heart failure is growing. The prevalence and incidence in industrialised countries are estimated to be around 1% and 0.15% of the population, respectively. Up to 10% of people with heart failure are at an advanced stage, amounting to 300 000 patients in the U...
متن کاملChanges in sarcolemmal PLC isoenzymes in postinfarct congestive heart failure: partial correction by imidapril.
We have examined the changes in quantity and activity of cardiac sarcolemmal (SL) phosphoinositide-phospholipase C (PLC)-β1, -γ1, and -δ1 in a model of congestive heart failure (CHF) secondary to large transmural myocardial infarction (MI). We also instituted a late in vivo monotherapy with imidapril, an ANG-converting enzyme (ACE) inhibitor, to test the hypothesis that its therapeutic action i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: PLOS ONE
سال: 2020
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0237810